1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2024 | |
|---|---|---|
| Revenue | 7.87M | 89.92% |
| Gross profit | 7.87M | 89.92% |
| Net profit | 32.85M | 56.35% |
| EBITDA | 0 | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €457.7M |
Number of shares | 335.91M |
52-week high/low | €1.39 - €0.0104 |
| Dividends | No |
Beta | 0.60 |
P/E ratio | 4.00 |
PEG ratio | 0.00 |
P/B ratio | 1.22 |
P/S ratio | 5.26 |
Company profile
RTW Venture Fund Limited hat sich auf die Suche nach transformativen Unternehmen mit hohem Wachstumspotenzial in den Bereichen Biowissenschaften, Biopharmazie und Medizintechnik spezialisiert. Der Fonds investiert in Unternehmen, die Therapien und Technologien der nächsten Generation entwickeln, die das Leben von Patienten erheblich verbessern können.
| Name | RTW VENTURE FUND LTD |
| CEO | Krisha McCune |
| Headquarters | New York City,
ny Guernsey |
| Website | |
| IPO | 11/10/2022 |
Ticker symbols
| Exchange | Symbol |
|---|---|
London Stock Exchange | RTW.L |
London Stock Exchange | RTWG.L |
London | RTWG.L |
München | 0BM.MU |
Discover assets
Shareholders of RTW VENTURE FUND LTD also invest in the following assets
